Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a White Capsule 16 mm, Tablet with imprint "INCY;20". It contains Ruxolitinib 20.0 mg; of Ruxolitinib[ruxolitinib];. This belongs to the Kinase inhibitor pharmacologic class. It is manufactured by Incyte Corporation. For details please contact your physician.
Basic Information
- Imprint
- INCY;20
- Color
- White
- Shape
- Capsule
- Size
- 16 mm
Drug Information
- Strength
- Ruxolitinib 20.0 mg;
- Dosage Form
- Tablet
- RxCUI
- 1193349
Pharmaceutical Classification
- Pharmacologic Class
- Kinase inhibitor
Related Medications
Other drugs in the same class: Kinase Inhibitor
- AfinitorEVEROLIMUS 10 mg;WHITE • OVAL
- AfinitorEVEROLIMUS 5 mg;WHITE • OVAL
- BOSULIFBOSUTINIB MONOHYDRATE 500 mg;RED • OVAL
- GleevecIMATINIB MESYLATE 100 mg;YELLOW • ROUND
- GleevecIMATINIB MESYLATE 400 mg;YELLOW • OVAL
- Imatinib MesylateIMATINIB MESYLATE 100 mg;YELLOW • ROUND
- Imatinib MesylateIMATINIB MESYLATE 400 mg;YELLOW • OVAL
- ImbruvicaIBRUTINIB 140 mg;WHITE • CAPSULE
- INLYTAAXITINIB 1 mg;RED • OVAL
- INLYTAAXITINIB 5 mg;RED • TRIANGLE
Ingredients
- Active Ingredients
- Ruxolitinib[ruxolitinib];
- Inactive Ingredients
- Cellulose, microcrystalline;lactose monohydrate;silicon dioxide;hydroxypropyl cellulose (70000 wamw);povidone;sodium starch glycolate type a potato;magnesium stearate;
Additional Information
- Manufacturer
- Incyte Corporation
- Status (Rx/OTC)
- Rx
- Brand Names
- Jakafi
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.